For the Inventor, By the Inventor

Enter assignee name

Nijmegen, Netherlands

Interna Technologies B.v.

USPTO Granted Patents = 8

CIPO Patents = 4

EPO Patents = 5

Forward Citations = 12

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Roeland Quirinus Jozef Schaapveld (8 out of 9 patents)

Willemijn Maria Gommans (6 out of 7 patents)

Eugene Berezikov (4 out of 7 patents)

4. Rick Jan Van Haastert (4 out of 5 patents)

5. Sanne Weijzen (4 out of 4 patents)

6. Petronella Innocentia Van Noort (3 out of 3 patents)

7. Grégoire Pierre André Prevost (3 out of 4 patents)

8. Jacobus Antonius Schalken (2 out of 6 patents)

9. Meriem Bourajjaj (2 out of 2 patents)

10. Arjan Willem Griffioen (2 out of 5 patents)

11. Edwin Pieter Johan Gerard Cuppen (2 out of 2 patents)

12. Andreas Alphons Franciscus Ludovicus Van Puijenbroek (2 out of 2 patents)

13. Negar Babae (2 out of 2 patents)

14. Jos Bernard Poell (1 out of 2 patents)

15. Andreas Alphons F L Van Puijenbroek (1 out of 2 patents)

8 patents: Sort by Forward Citations

1. 11497762 - MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation (2022-11-15),

2. 10201556 - Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway (2019-02-12),

3. 10174314 - MiRNA for treating head and neck cancer (2019-01-08),

4. 10023868 - MiRNA for treating diseases and conditions associated with neo-angiogenesis (2018-07-17),

5. 9944932 - MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT (2018-04-17),

6. 9682095 - MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway (2017-06-20),

7. 9441222 - MiRNA for treating diseases and conditions associated with neo-angiogenesis (2016-09-13),

8. 9161947 - MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT (2015-10-20),

Interna Technologies B.v. is a leading technology company specializing in providing innovative IT solutions for businesses. With a strong focus on software development, cloud services, and cybersecurity, Interna Technologies helps clients optimize their operations and enhance their digital presence. The company's team of experts is committed to delivering high-quality services to meet the unique needs of each client.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#8 in Nijmegen

#732 in Netherlands

Nijmegen, Netherlands

Interna Technologies B.v.

Forward Citations = 12

37 inventors:

Roeland Quirinus Jozef Schaapveld (8 out of 9 patents)

Willemijn Maria Gommans (6 out of 7 patents)

Eugene Berezikov (4 out of 7 patents)

4. Rick Jan Van Haastert (4 out of 5 patents)

5. Sanne Weijzen (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…